|Immune evasion in cancer: Mechanistic basis and therapeutic strategies|
DS Vinay, EP Ryan, G Pawelec, WH Talib, J Stagg, E Elkord, T Lichtor, ...
Seminars in cancer biology 35, S185-S198, 2015
|Broad targeting of resistance to apoptosis in cancer|
RM Mohammad, I Muqbil, L Lowe, C Yedjou, HY Hsu, LT Lin, MD Siegelin, ...
Seminars in cancer biology 35, S78-S103, 2015
|Tissue invasion and metastasis: Molecular, biological and clinical perspectives|
WG Jiang, AJ Sanders, M Katoh, H Ungefroren, F Gieseler, M Prince, ...
Seminars in cancer biology 35, S244-S275, 2015
|Sustained proliferation in cancer: Mechanisms and novel therapeutic targets|
MA Feitelson, A Arzumanyan, RJ Kulathinal, SW Blain, RF Holcombe, ...
Seminars in cancer biology 35, S25-S54, 2015
|Broad targeting of angiogenesis for cancer prevention and therapy|
Z Wang, C Dabrosin, X Yin, MM Fuster, A Arreola, WK Rathmell, ...
Seminars in cancer biology 35, S224-S243, 2015
|Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm|
JL Dennis, TR Hvidsten, EC Wit, J Komorowski, AK Bell, I Downie, ...
Clinical Cancer Research 11 (10), 3766-3772, 2005
|Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells|
M Agochiya, VG Brunton, DW Owens, EK Parkinson, C Paraskeva, ...
Oncogene 18 (41), 5646-5653, 1999
|Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells|
G Saretzki, T Walter, S Atkinson, JF Passos, B Bareth, WN Keith, ...
Stem cells 26 (2), 455-464, 2008
|Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition|
LR Ferguson, H Chen, AR Collins, M Connell, G Damia, S Dasgupta, ...
Seminars in cancer biology 35, S5-S24, 2015
|Cancer prevention and therapy through the modulation of the tumor microenvironment|
SC Casey, A Amedei, K Aquilano, AS Azmi, F Benencia, D Bhakta, ...
Seminars in cancer biology 35, S199-S223, 2015
|Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer|
AI Soder, SF Hoare, S Muir, JJ Going, EK Parkinson, WN Keith
Oncogene 14 (9), 1013-1021, 1997
|Designing a broad-spectrum integrative approach for cancer prevention and treatment|
KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ...
Seminars in cancer biology 35, S276-S304, 2015
|Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa|
JJ Going, WN Keith, L Neilson, K Stoeber, RC Stuart, GH Williams
Gut 50 (3), 373-377, 2002
|Targeting telomerase for cancer therapeutics|
JW Shay, WN Keith
British journal of cancer 98 (4), 677-683, 2008
|A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A|
X Zhang, I Neganova, S Przyborski, C Yang, M Cooke, SP Atkinson, ...
The Journal of cell biology 184 (1), 67-82, 2009
|Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity|
CJ Cairney, WN Keith
Biochimie 90 (1), 13-23, 2008
|Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15. 33 by fluorescence in situ hybridization|
LA Bryce, N Morrisont, SF Hoare, S Muir, WN Keith
Neoplasia 2 (3), 197-201, 2000
|Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors|
C Dufes, WN Keith, A Bilsland, I Proutski, IF Uchegbu, AG Schätzlein
Cancer research 65 (18), 8079-8084, 2005
|Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases|
F Al‐Mulla, WN Keith, IR Pickford, JJ Going, GD Birnie
Genes, Chromosomes and Cancer 24 (4), 306-314, 1999
|Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters|
SP Atkinson, SF Hoare, RM Glasspool, WN Keith
Cancer research 65 (17), 7585-7590, 2005